Adagene ADAG
NASDAQ ADAG
$2.13 +0.08 (+3.90%)
At close: Nov 11, 2026 · 4:00 PM EST

Adagene (ADAG) Current Leases (2022 - 2026)

Updated

Analysis

Adagene (ADAG) Current Leases (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Adagene 97.14 Mn -253.32 Mn - 181,733.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181,733.00
Dec 31, 2025 92,055.00
Jun 30, 2025 125,851.00
Dec 31, 2024 141,341.00
Jun 30, 2024 141,281.00
Dec 31, 2023 195,955.00
Jun 30, 2023 158,859.00
Dec 31, 2022 151,983.00
Jun 30, 2022 297,066.00
API Access

Adagene Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=ADAG&period=max&api_key=YOUR_API_KEY